Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionUndisclosed compound targeting prepronociceptin (PNOC; NOP)
Molecular Target Prepronociceptin (PNOC) (NOP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat major depressive disorder (MDD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today